Back to search
Cytospire Therapeutics Limited
14688240
active
Private Limited Company
england wales
Health Score
63 / 100
Some Concerns
25/30
Filing
0/30
Financial
38/40
Risk
- 1 outstanding charge (-2)
Details
3RD FLOOR, ALTRINCHAM, WA14 2DT
Incorporated 24/02/2023
Compliance
Last accounts
31/03/2026
small
Next accounts due
31/12/2027
On track
Confirmation statement
Last: 23/02/2026
Due 09/03/2027
On track
Industry
72110
Research and experimental development on biotechnologyOfficers
Mr Balaji Muralidhar
director · Since 02/05/2023
CHIEF INVESTMENT OFFICER
BRITISH · ENGLAND
Also on 5 other boards
Mr Owen Philip Smith
director · Since 22/11/2023
PARTNER
BRITISH · UNITED KINGDOM
Also on 2 other boards
Persons with Significant Control
Abingworth Bioventures 8 Gp Lp
25–50% shares
25–50% votes
Reg: Sl034057 · Companies House · Corporate
Notified 28/04/2023
Former PSCs
Natalie Marianne Mount
Ceased 30/11/2023
Mark Uden
Ceased 30/11/2023
4bio Ventures Iii Gp Llp
Ceased 03/10/2024
Charges1 outstanding
Charge
outstanding
HSBC INNOVATION BANKING
Created 18/08/2023Registered 22/08/2023
Charge
satisfied
HSBC INNOVATION BANKING PREVIOUSLY KNOWN AS SILICON VALLEY BANK UK LIMITED
Created 29/06/2023Registered 04/07/2023Satisfied 11/07/2024